insitro
Ziad Bakri is a portfolio manager and Vice President at T. Rowe Price, which he joined in 2011. Ziad is the sector leader of T. Rowe’s Health Care research team and manager of the $22 billion T. Rowe Price Health Sciences Strategy, investing broadly in public and private companies across all healthcare subsectors. Ziad received his medical degree from the University of Nottingham in 2003, and was an E.R. resident in London before joining Cowen and Company in New York as a biotechnology analyst in 2006. Ziad earned his undergraduate Bachelor of medical sciences degree (First class honors) from the University of Nottingham, UK, and holds the CFA designation.
This person is not in the org chart
This person is not in any offices
insitro
6 followers
insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.